The backlash against bioequivalence and the interchangeability of brand-name and generic drugs.
作者信息
Kesselheim Aaron S
机构信息
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass., USA.
出版信息
CMAJ. 2011 Sep 6;183(12):1350-1. doi: 10.1503/cmaj.110808. Epub 2011 Jul 11.
Abstract
摘要
相似文献
1
The backlash against bioequivalence and the interchangeability of brand-name and generic drugs.对生物等效性以及品牌药和仿制药可互换性的强烈反对。
CMAJ. 2011 Sep 6;183(12):1350-1. doi: 10.1503/cmaj.110808. Epub 2011 Jul 11.
2
Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations.胺碘酮致甲状腺功能紊乱：原研药与仿制药。
CMAJ. 2011 Sep 6;183(12):E817-23. doi: 10.1503/cmaj.101800. Epub 2011 Jul 11.
3
Treatment guidelines for hyperthyroidism and hypothyroidism.甲状腺功能亢进和减退的治疗指南。
JAMA. 1995 Oct 4;274(13):1011; author reply 1011-2. doi: 10.1001/jama.274.13.1011c.
4
Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation.胺碘酮治疗持续性心房颤动期间的甲状腺功能异常
Am J Med. 2007 Oct;120(10):880-5. doi: 10.1016/j.amjmed.2007.04.022.
5
Amiodarone for atrial fibrillation.用于心房颤动的胺碘酮。
N Engl J Med. 2007 Jun 7;356(23):2424-6; author reply 2424-6.
6
[Amiodarone and the thyroid].[胺碘酮与甲状腺]
Cardiologia. 1995 Dec;40(12 Suppl 1):173-8.
7
[Antiarrhythmic drugs in atrial fibrillation].[心房颤动中的抗心律失常药物]
Rev Prat. 2002 Dec 15;52(20):2239.
8
Amiodarone for atrial fibrillation.用于心房颤动的胺碘酮。
N Engl J Med. 2007 Jun 7;356(23):2424-6; author reply 2424-6.
9
[Amiodarone: treatment or cause of atrial fibrillation?].[胺碘酮：是房颤的治疗手段还是病因？]
Rev Med Suisse. 2005 Nov 2;1(39):2533-5.
10
[Amiodarone treatment against atrial fibrillation caused thyrotoxicosis].胺碘酮治疗房颤所致甲状腺毒症
Lakartidningen. 2005;102(16):1231-3.
引用本文的文献
1
Analysis on the Impact of U.S. FDA's Narrow Therapeutic Index Bioequivalence Criteria on Generic Drug Applications.美国食品药品监督管理局窄治疗指数生物等效性标准对仿制药申请的影响分析
AAPS J. 2025 Feb 12;27(1):42. doi: 10.1208/s12248-025-01020-1.
2
Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients.米卡芬净群体药代动力学模型的评估：对危重症患者给药方案优化的意义
Pharmaceutics. 2024 Aug 29;16(9):1145. doi: 10.3390/pharmaceutics16091145.
3
Population Pharmacokinetics of Levetiracetam: A Systematic Review.左乙拉西坦的群体药代动力学：系统评价。
Clin Pharmacokinet. 2021 Mar;60(3):305-318. doi: 10.1007/s40262-020-00963-2. Epub 2021 Jan 15.
4
China's new policy for healthcare cost-control based on global budget: a survey of 110 clinicians in hospitals.中国基于总额预算的医疗费用控制新政策：对110名医院临床医生的调查
BMC Health Serv Res. 2019 Feb 1;19(1):84. doi: 10.1186/s12913-019-3921-8.
5
Impact of brand-name drug worship and expectation psychology on antidepressant efficacy.品牌药崇拜和期望心理对抗抑郁药疗效的影响。
Int J Clin Exp Med. 2013 Sep 1;6(8):724-6. eCollection 2013.
6
Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study.拉莫三嗪在具有不同适应证的医疗补助患者中的通用替代：一项队列交叉研究。
CNS Drugs. 2012 Aug 1;26(8):707-16. doi: 10.2165/11634260-000000000-00000.
本文引用的文献
1
Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations.胺碘酮致甲状腺功能紊乱：原研药与仿制药。
CMAJ. 2011 Sep 6;183(12):E817-23. doi: 10.1503/cmaj.101800. Epub 2011 Jul 11.
2
The consequences of requesting "dispense as written".要求“照方发药”的后果。
Am J Med. 2011 Apr;124(4):309-17. doi: 10.1016/j.amjmed.2010.11.020.
3
Acute epilepsy exacerbations in patients switched between A-rated anti-epileptic drugs.A 级抗癫痫药物转换后患者的癫痫急性发作恶化。
Curr Med Res Opin. 2010 Feb;26(2):455-63. doi: 10.1185/03007990903488704.
4
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.比较仿制药和创新药：对美国食品药品监督管理局12年生物等效性数据的综述
Ann Pharmacother. 2009 Oct;43(10):1583-97. doi: 10.1345/aph.1M141. Epub 2009 Sep 23.
5
The risks and costs of multiple-generic substitution of topiramate.托吡酯多晶型替代的风险和成本。
Neurology. 2009 Jun 16;72(24):2122-9. doi: 10.1212/WNL.0b013e3181aa5300.
6
Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.心血管疾病中使用的仿制药和品牌药的临床等效性：一项系统评价和荟萃分析。
JAMA. 2008 Dec 3;300(21):2514-26. doi: 10.1001/jama.2008.758.
7
Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.关于抗惊厥药物治疗癫痫的覆盖范围的立场声明。
Neurology. 2007 Apr 17;68(16):1249-50. doi: 10.1212/01.wnl.0000259400.30539.cc.
8
The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.选择的影响：开具通用药物或首选药物可提高慢性病患者的用药依从性。
Arch Intern Med. 2006 Feb 13;166(3):332-7. doi: 10.1001/archinte.166.3.332.
9
Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmias.非专利抗心律失常药物在治疗快速性心律失常方面并非治疗等效。
Am J Cardiol. 2000 May 1;85(9):1151-3, A10. doi: 10.1016/s0002-9149(00)00715-3.
Zotero 插件